TY  - RPRT
TI  - Synthetic lethality screening reveals FDA-approved drugs that overcome ATP7B-mediated tolerance of tumor cells to cisplatin
AU  - Mariniello, M.
AU  - Petruzzelli, R.
AU  - Wanderlingh, L.
AU  - La Montagna, R.
AU  - Carissimo, A.
AU  - Pane, F.
AU  - Amoresano, A.
AU  - Medina, D.
AU  - Polishchuk, R.
PY  - 2019
DO  - 10.1101/568535
UR  - https://www.biorxiv.org/content/10.1101/568535v1
ID  - 10.1101/568535
ER  -